BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alves MT, Simões R, Pestana RMC, de Oliveira AN, Oliveira HHM, Soares CE, Sabino AP, Silva LM, Gomes KB. Interleukin-10 Levels are Associated with Doxorubicin-Related Cardiotoxicity in Breast Cancer Patients in a One-Year Follow-Up Study. Immunol Invest 2021;:1-16. [PMID: 33557640 DOI: 10.1080/08820139.2021.1882486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Pestana RMC, Alves MT, de Oliveira AN, Oliveira HHM, Soares CE, Sabino AP, Silva LM, Simões R, Gomes KB. Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy. Blood Coagul Fibrinolysis 2023;34:70-4. [PMID: 35946469 DOI: 10.1097/MBC.0000000000001159] [Reference Citation Analysis]
2 Bhagat A, Shrestha P, Kleinerman ES. The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity. Int J Mol Sci 2022;23. [PMID: 36498974 DOI: 10.3390/ijms232314649] [Reference Citation Analysis]
3 Adler AJ. Letter from the Editor: 2022. Immunol Invest 2022;51:2123-7. [PMID: 36548098 DOI: 10.1080/08820139.2022.2146509] [Reference Citation Analysis]